ĀÜĄņĀŅĀ×

James Miller is an accomplished executive with extensive experience in the biotechnology and pharmaceuticals sectors. As Chief Operating Officer at F3 Platform Biologics, Inc. since October 2018, James has overseen all operations and guided the company's IPO process. James currently serves as Executive Vice President at Quantum Materials Corp and as a Board Member for Xylogenics, Inc., while also holding advisory positions and leadership roles in various companies, including Algaeon, Inc. and Pinnacle Biologics, Inc. Notable achievements include repositioning Algaeon's business strategy, leading international operations at Grifols, and co-founding Pinnacle Biologics. James's educational background includes a BA in Accounting from Hillsdale College.